Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial.

Trials

Busard C, Menting S, van Bezooijen SJ, van den Reek J, Hutten B, Prens E, de Jong E, van Doorn M, Spuls P.
PMID: 28270175
Trials. 2017 Mar 07;18(1):113. doi: 10.1186/s13063-017-1848-0.

No abstract available.

Cite
Busard C, Menting S, van Bezooijen SJ, et al. Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial. Trials. 2017;18(1):113doi: 10.1186/s13063-017-1848-0.
Busard, C., Menting, S., van Bezooijen, S. J., van den Reek, J., Hutten, B., Prens, E., de Jong, E., van Doorn, M., & Spuls, P. (2017). Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial. Trials, 18(1), 113. https://doi.org/10.1186/s13063-017-1848-0
Busard, Celine, et al. "Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial." Trials vol. 18,1 (2017): 113. doi: https://doi.org/10.1186/s13063-017-1848-0
Busard C, Menting S, van Bezooijen SJ, van den Reek J, Hutten B, Prens E, de Jong E, van Doorn M, Spuls P. Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial. Trials. 2017 Mar 07;18(1):113. doi: 10.1186/s13063-017-1848-0. PMID: 28270175; PMCID: PMC5341450.
Copy Download .nbib Format: NLM
Feasibility and acceptability of follow-up for prostate cancer in primary care: a pilot study.

BJGP open

Heins M, Schellevis F, Schotman M, van Bezooijen B, Tchaoussoglou I, van der Waart M, Veldhuis L, van Dulmen S, Donker G, Korevaar J.
PMID: 30723802
BJGP Open. 2018 Dec 12;2(4):bjgpopen18X101616. doi: 10.3399/bjgpopen18X101616. eCollection 2018 Dec.

BACKGROUND: The number of patients with prostate cancer is increasing, which puts additional pressure on health care. GP-led follow up may help reduce costs, travel time for patients, and workload for urologists and improve continuity of care.AIM: To test...

Cite
Heins M, Schellevis F, Schotman M, et al. Feasibility and acceptability of follow-up for prostate cancer in primary care: a pilot study. BJGP Open. 2018;2(4):bjgpopen18X101616doi: 10.3399/bjgpopen18X101616.
Heins, M., Schellevis, F., Schotman, M., van Bezooijen, B., Tchaoussoglou, I., van der Waart, M., Veldhuis, L., van Dulmen, S., Donker, G., & Korevaar, J. (2018). Feasibility and acceptability of follow-up for prostate cancer in primary care: a pilot study. BJGP open, 2(4), bjgpopen18X101616. https://doi.org/10.3399/bjgpopen18X101616
Heins, Marianne, et al. "Feasibility and acceptability of follow-up for prostate cancer in primary care: a pilot study." BJGP open vol. 2,4 (2018): bjgpopen18X101616. doi: https://doi.org/10.3399/bjgpopen18X101616
Heins M, Schellevis F, Schotman M, van Bezooijen B, Tchaoussoglou I, van der Waart M, Veldhuis L, van Dulmen S, Donker G, Korevaar J. Feasibility and acceptability of follow-up for prostate cancer in primary care: a pilot study. BJGP Open. 2018 Dec 12;2(4):bjgpopen18X101616. doi: 10.3399/bjgpopen18X101616. eCollection 2018 Dec. PMID: 30723802; PMCID: PMC6348321.
Copy Download .nbib Format: NLM
Age-related changes in distribution of cytochrome P-450 in the hepatic lobule of the rat.

Archives of gerontology and geriatrics

Machida T, Miyatake M, van Bezooijen CF.
PMID: 15374492
Arch Gerontol Geriatr. 1990 Jul-Aug;11(1):43-52. doi: 10.1016/0167-4943(90)90055-b.

The effect of age on distribution of the phenobarbital-inducible forms of cytochrome P-450 IIBI and IIB2 in the hepatic lobule was investigated immunohistochemically by the avidin-biotin-peroxidase complex (ABC) method in male rats of various ages pretreated with phenobarbital. Exposure...

Cite
Machida T, Miyatake M, van Bezooijen CF. Age-related changes in distribution of cytochrome P-450 in the hepatic lobule of the rat. Arch Gerontol Geriatr. 1990;11(1):43-52doi: 10.1016/0167-4943(90)90055-b.
Machida, T., Miyatake, M., & van Bezooijen, C. F. (1990). Age-related changes in distribution of cytochrome P-450 in the hepatic lobule of the rat. Archives of gerontology and geriatrics, 11(1), 43-52. https://doi.org/10.1016/0167-4943(90)90055-b
Machida, T, et al. "Age-related changes in distribution of cytochrome P-450 in the hepatic lobule of the rat." Archives of gerontology and geriatrics vol. 11,1 (1990): 43-52. doi: https://doi.org/10.1016/0167-4943(90)90055-b
Machida T, Miyatake M, van Bezooijen CF. Age-related changes in distribution of cytochrome P-450 in the hepatic lobule of the rat. Arch Gerontol Geriatr. 1990 Jul-Aug;11(1):43-52. doi: 10.1016/0167-4943(90)90055-b. PMID: 15374492.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries